531237 | IRAK4 Inhibitor, Compound 26 - Calbiochem

531237
価格が見つかりません
Minimum Quantity needs to be mulitiple of
弊社照会 詳細を表示 
値引
()
 
弊社照会
現在国内在庫なし現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      価格&在庫状況を照会
      クリックして印刷用に表示

      概要

      Replacement Information

      主要スペック表

      Empirical Formula
      C₂₅H₂₇N₅O₂

      価格&在庫状況

      カタログ番号在庫状況 包装 Qty/Pk 価格 数量
      5.31237.0001
      在庫状況検索中…
      現在国内在庫なし現在国内在庫なし
      現在国内在庫有り 
      販売中止
      在庫僅少
      現在国内在庫あり
        Remaining : Will advise
          Remaining : Will advise
          注文対象外
          お問合せください

          ガラスビン 10 mg
          価格を検索中…
          価格が見つかりません
          Minimum Quantity needs to be mulitiple of
          弊社照会 詳細を表示 
          値引
          ()
           
          弊社照会
          Description
          OverviewA cell permeable indolo[2,3-c]quinoline derivatived compound that acts as a selective and highly potent inhibitor of interleukin-1 receptor associated kinase (IRAK4; IC50 = 94 pM). Displays much reduced potency against IRAK1 (IC50 = 65 nM) and displays high selectivity over a panel of other 27 kinases, including several involved in TLR-mediated signaling. Blocks R848-induced TNF-α and IL-6 production in primary human monocytes and inhibits LPS-induced TNF-α production in mice (100 mpk). Shows minimal inhibition of Cyp2C9, 2D6, and 3A4 and has excellent microsomal stability and desirable aqueous solubility (100 μg/ml at pH 7.4).

          Please note that the molecular weight for this compound is batch-specific due to variable water content.
          Catalogue Number531237
          Brand Family Calbiochem®
          SynonymsInterleukin-1 Receptor Associated Kinase 4 Inhibitor
          References
          ReferencesTumey, L.N., et al. 2014 Bioorg. Med. Chem. Lett. 24, 2066.
          Product Information
          FormPale yellow powder
          Hill FormulaC₂₅H₂₇N₅O₂
          Chemical formulaC₂₅H₂₇N₅O₂
          ReversibleY
          Applications
          Biological Information
          Primary TargetIRAK4
          Primary Target IC<sub>50</sub>94 pM
          Purity≥98% by HPLC
          Physicochemical Information
          Cell permeableY
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
          Toxicity Standard Handling
          Storage +2°C to +8°C
          Protect from Light Protect from light
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          (M)SDS

          タイトル

          英語版製品安全データシート((M)SDS) 

          参考資料

          参考資料の概要
          Tumey, L.N., et al. 2014 Bioorg. Med. Chem. Lett. 24, 2066.

          カタログ

          タイトル
          NPI Flyer- Epigenetics and Nuclear Function Feature
          New Products - Antibodies, Small Molecule, Inhibitors (MM)

          技術情報

          タイトル
          White Paper: Further considerations of antibody validation and usage.
          データシート

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision17-August-2017 JSW
          SynonymsInterleukin-1 Receptor Associated Kinase 4 Inhibitor
          DescriptionA cell permeable indolo[2,3-c]quinoline derivatived compound that acts as a selective and highly potent inhibitor of interleukin-1 receptor associated kinase (IRAK4; IC50 = 94 pM). Displays much reduced potency against IRAK1 (IC50 = 65 nM) and displays high selectivity over a panel of other 27 kinases, including several involved in TLR-mediated signaling. Blocks R848-induced TNF-α and IL-6 production in primary human monocytes and inhibits LPS-induced TNF-α production in mice (100 mpk). Shows minimal inhibition of Cyp2C9, 2D6, and 3A4 and has excellent microsomal stability and desirable aqueous solubility (100 μg/ml at pH 7.4).
          FormPale yellow powder
          Intert gas (Yes/No) Packaged under inert gas
          Chemical formulaC₂₅H₂₇N₅O₂
          Purity≥98% by HPLC
          SolubilityDMSO (50 mg/ml)
          Storage +2°C to +8°C
          Protect from light
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Toxicity Standard Handling
          ReferencesTumey, L.N., et al. 2014 Bioorg. Med. Chem. Lett. 24, 2066.